Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5139]
News [14902]
Articles [105]
Editorials [3]
Conferences [246]
elearning [21]
Activating p53 and cell senescence to regress tumours
Dr Karen Vousden - Beatson Institute for Cancer Research, Glasgow
Activating p53 and cell senescence to regress tumours ( Dr Karen Vousden - Beatson Institute for Cancer Research, Glasgow )
8 Jul 2009
Genetic determinants for breast cancer spread
Dr Kent Hunter - National Cancer Institute, Bethesda, USA
Genetic determinants for breast cancer spread ( Dr Kent Hunter - National Cancer Institute, Bethesda, USA )
8 Jul 2009
Mouse models to ID genetic controls and 3D models to help personalise therapy
Dr Marco Pieroti - National Cancer Institute, Milan, Italy
Mouse models to ID genetic controls and 3D models to help personalise therapy ( Dr Marco Pieroti - National Cancer Institute, Milan, Italy )
8 Jul 2009
Selecting appropriate first line lung cancer therapy
Dr Paul Bunn - University of Colorado, Denver, USA
Selecting appropriate first line lung cancer therapy ( Dr Paul Bunn - University of Colorado, Denver, USA )
8 Jul 2009
Studying genetics behind drug resistance using cell culture models
Dr René Bernards - Netherlands Cancer Institute, Amsterdam
Studying genetics behind drug resistance using cell culture models ( Dr René Bernards - Netherlands Cancer Institute, Amsterdam )
8 Jul 2009
MicroRNAs regulating cancer stem cell self renewal
Dr Michael Clarke - Stanford School of Medicine, USA
MicroRNAs regulating cancer stem cell self renewal ( Dr Michael Clarke - Stanford School of Medicine, USA )
8 Jul 2009
Study of the extra cellular matrix around cancer cells and 3D assays
Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA
Study of the extra cellular matrix around cancer cells and 3D assays ( Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA )
8 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer ( Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US )
3 Jul 2009
AACR 2009: Tackling the p53 gene and side effects
Professor David Lane - Director of the Cancer Research UK Transformation...
AACR 2009: Tackling the p53 gene and side effects ( Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee )
18 May 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009
AACR 2009: Chemokine inhibitors to prevent tumour growth
Prof Alberto Mantovani - Professor of General Pathology, University of Milan
AACR 2009: Chemokine inhibitors to prevent tumour growth ( Prof Alberto Mantovani - Professor of General Pathology, University of Milan )
14 May 2009
AACR 2009: Cancer stem cells and leukaemia
Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School...
AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )
14 May 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation